copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Thor Medical | Alpha emitters for cancer therapy Thor Medical is a producer and supplier of alpha-particle emitters for cancer therapy The production process is based on separation of natural occurring radioactive decay products from thorium (Th-232)
Nordic Nanovector to merge with APIM after Betalutin fail Five months after giving up on its lead drug Betalutin for follicular lymphoma, Nordic Nanovector has charted a course forward via a merger with fellow Norwegian biotech APIM Therapeutics
Nordic Nanovector Launches Dedicated Area on its Website in Norwegian . . . Issuer Thor Medical ASA Oslo, Norway, 25 November 2022 Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") has today launched a new dedicated area on its website (www nordicnanovector com) with information in Norwegian for shareholders relating to its proposed merger
Nordic Nanovector - Carnegie Norway Nordic Nanovector ASA announced 6th of June the signing of an agreement to acquire Thor Medical AS, a privately held company focused on the production of alpha-emitting radionuclides for cancer treatment, in an all-share transaction
Nordic Nanovector announces agreement to acquire Thor Medical Nordic Nanovector ASA (OSE: NANOV) and Thor Medical AS, a privately held company focused on the production of alpha-emitting radionuclides for cancer treatment, today announce that they have entered into a definitive share exchange agreement to combine the two companies in an all-share transaction
Nordic Nanovector AS - VentureRadar Nordic Nanovector AS is a privately held company based in Oslo, Norway The company was established in 2009 Our mission is to develop innovative radioimmunotherapeutics that target difficult to treat cancers using the company’s proprietary nanovector targeting technology
Orphanet: NORDIC NANOVECTOR AS The documents contained in this website are presented for information purposes only The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment